|Bid||23.01 x 900|
|Ask||28.25 x 800|
|Day's Range||23.68 - 24.77|
|52 Week Range||18.85 - 25.77|
|Beta (3Y Monthly)||0.36|
|PE Ratio (TTM)||10.45|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Cash and cash equivalents and Short term investments increased by 48% to $29.0 million during the fiscal year ended June 30, 2019.Total Revenues-Net increased by 7% to $87.2.
Total Revenues – Net increased 9% to $22.8 million, for the third quarter and 7% to $64.7 million for the nine-month period ended March 31, 2019, versus same period during prior.
FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning™, reported today it is holding its annual shareholder meeting on May 20, 2019, in Wilmington, DE. The proxy statement, filed on Friday, April 5, 2019, contains the annual FONAR CHAIRMAN’S LETTER TO SHAREHOLDERS.
FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning™, reported today publication of a chapter where the physician-author-researchers utilized the FONAR UPRIGHT® Multi-Position™ MRI. The title of their chapter is: Craniocervical Junction Syndrome: Anatomy of the Craniocervical and Atlantoaxial Junctions and the Effect of Misalignment on Cerebrospinal Fluid Flow. Please click on https://www.fonar.com/news/031419.htm to see the complete press release with its images and captions.
Total Revenues – Net, increased 6% to $41.9 million, for the six month period ended December 31, 2018, versus same six month period during prior year.Income from Operations.
NEW YORK, Feb. 05, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
FONAR Corporation (NASDAQ-FONR), Inventor of MR Scanning™, reported that its founder, chairman of the board and past president, Raymond V. Damadian, M.D. received the Excellence in Medicine award from the Chiari & Syringomyelia Foundation (CSF), on November 10, 2018, at Brooks’s, London, England. Dr. Damadian was introduced by Fraser C. Henderson, Sr., M.D., a neurosurgeon and a member of the steering committee for the Chiari & Syringomyelia Foundation and Professor Donlin Long, M.D., former Chairman of Neurosurgery at Johns Hopkins University.
Income from Operations increased 16% to $5.5 million, for the quarter ended September 30, 2018, versus same quarter one year earlier.Net Income decreased by 2% to $4.5 million.